Net Asset Value(s)
23 Mai 2005 - 4:06PM
UK Regulatory
RNS Number:6356M
Finsbury Life Sciences Inv Tst PLC
23 May 2005
FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC
NET ASSET VALUE
The estimated unaudited net asset value, calculated in accordance with the
guidelines of the Association of Investment Trust Companies, for Finsbury
Emerging Biotechnology Trust PLC at the close of business on 20 May 2005 was
99.27p (ex income).
The estimated NAV above includes the Company's interest in the Merlin Fund LP ('
Merlin'), which holds listed investments, cash and unlisted investments. The
Company's pro rata share of unquoted securities in Merlin represents 4.6% of the
Company's estimated net asset value. The pro rata share of the listed
securities and cash in Merlin represent 5.0% and 0.6% respectively of the
Company's estimated NAV. The Company also holds unquoted securities
representing a further 4.9% of the Company's estimated net asset value.
For and on behalf of the Board
Close Finsbury Asset Management Limited
Secretary
23 May 2005
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVPUUQUAUPAGCW
Flightstore (LSE:FLS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Flightstore (LSE:FLS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
Echtzeit-Nachrichten über Flightstore (Londoner Börse): 0 Nachrichtenartikel
Weitere Finsbury Life SC Plc News-Artikel